The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Does anyone know the actual free float in this stock please, as I can't find the Significant s/holder list section on their website?
Add up all the holdings positions - they come to around 82% - so tiny free float:
Herald Investment Management Limited
4,040,846
13.66
Alto Invest
2,885,410
9.76
i-nexus Global Directors & Related Holdings
2,749,702
9.30
Interactive Investor
2,403,954
8.13
Hargreaves Lansdown PLC
2,332,096
7.89
Antrak Limited
1,852,210
6.26
Gresham House plc
1,582,279
5.35
Bury Fitzwilliam-Lay and Partners
1,459,460
4.94
BPCE
1,250,000
4.23
The Capital for Enterprise Fund LLP
889,080
3.01
"I am disappointed that despite constructive discussions with RMS's advisers [Tuesday], the board of RMS has chosen to ride roughshod over shareholders' concerns. I believe that these would now be best satisfied by the cancellation of the warrants in their current form and comprehensive board changes which will allow myself and the Pharm 2 Farm team to concentrate on the many commercial opportunities presenting themselves," Cave said on Wednesday.
On Thursday, Cave said Remote Monitored Systems' advisers SP Angel Corporate Finance LLP have organised a virtual meeting to enable Alex Vergopoulos and Egremont Capital Ltd to speak with the board, noting that constructive discussions are now taking place between the parties.
https://www.lse.co.uk/news/BRH/remote-monitored-systems-to-hold-call-with-shareholder-after-dispute-2kvfb8z3b1xe3pa.html
anout 82% held by majority s/holders
https://i-nexus.com/investor-center/#1563894401151-a375625c-3547
Wrong, they already have the funding in place - the CRLN can convert into shares at 10p then they can hold or sell them - that's what it means - NOT only once the share price is 10p will they receive the funding
ill have the right to convert the Convertible Loan Notes they hold into ordinary shares of £0.10 each in the capital of the Company ("Ordinary Shares") at a price of 10 pence per Ordinary Share ("the Conversion Price") at any time on or prior to 4 November 2023.
Accordingly, the Directors have now been granted authority to issue the Convertible Loan Notes to the Investors. The Investors' commitments to subscribe for Convertible Loan Notes are now irrevocable and unconditional and settlement of the commitments of £1.325m is expected to take place later today.
https://www.investegate.co.uk/i-nexus-global-plc--inx-/rns/result-of-general-meeting/202011041115012557E/
https://www.investegate.co.uk/i-nexus-global-plc--inx-/rns/proposed-issue-of--1-325-million/202010190700074025C/
He sold about 95,000 shares only
That 400k trade makes up 4 76% of the share capital.....lets see if we get a seller on TR1 soon
Looking at the price.. that was a sell yesterday for 400k at circa 15p
Any views?
About Lind Partners
At Lind, we understand the challenges faced by management teams of growing companies.
By upholding our mission to be a responsible investor and a reliable financial partner, we have built a reputation as a leading provider of growth capital to the small- and mid-cap sector.
The Lind Partners is an institutional fund manager and leading provider of growth capital to small- and mid-cap companies publicly traded in the US, Canada, Australia and the UK. Lind targets high growth sectors such as technology, biotech, clean-tech, mining and oil & gas. Founded in 2011, Lind has a multi-faceted investment strategy: direct investments of new capital ($1 to $15 million initial investment); participation in syndicated equity placements; and on-market trades. Lind has completed over 70 direct investments for more than $850 million in total value and has an established reputation as a flexible and supportive capital partner to investee companies.
Http://www.thelindpartners.com/cgi-bin/index.pl
This is a good read about The Lind Partners, asset management firm that manages The Australian Special Opportunities Fund
Http://www.thelindpartners.com/documents/FG/lind_partners/news/207859_Mining_Journal_Mar_2014_-_Lind_Partners_Unearthing_Real_Value.pdf
It will cost much more than £400,000 to develop those Egyptian oil fields. So expect a placing to raise funding here. You don't get much for £400k
Thanks for your reply Tracy.
It's the huge influx of investors buying the shares that will help it re rate - rather than a handful - sentiment changes and more people buy into a sector or a share based on that. If it's regularly mentioned in the top ten then why isn't the market buying into the shares. Nothing is risk free, as you are well aware. Is there a close company listed comparison we can make with Enet? Why are UK small cap managed funds that can invest into small market cap co's like Enet not buying into this - they would of run the rule over this long ago.
But guess it comes at a good time to buy the shares now on a risk / reward basis before large contract news is / if gets released.
Reporting directly to the Marketing and Sales Manager, the successful candidate will be working in a “field based role” responsible for delivering all business development related activity within both academic and industry markets to consistently achieve sales based key performance indicators.
https://www.kirkstall.com/new-job-opportunity/
Hi Tracy,
Thanks for your informative post re: SmartNIC
However, how do you know you have picked the biggest winner here in Enet - do you know about all the other private companies with a similar business / products that Enet have - out of the vast com's out there globally that have these type of products - how are you so absolutely certain without fail that Enet is going to be the only biggest winner out there in the world?
Hi Bidnolid, have you seen a company called Calenex, epic CLX, they also deal with 5G business properties - not exactly sure what their business is in correlation to Enet's. But they have a £60m cap - recent IPO - worth comparing these 2 businesses, to see if their products are similar, or totally different
Huge discrepancy in the market caps
Paraytec has engaged with the regulatory agency processes to ensure that the trials and specifications of its test will meet or exceed the requirements that the relevant regulatory agency has set out and to ensure that the regulatory approval process is fast-tracked wherever this is possible.
Consequently, Braveheart now expects that the forecast cash costs of this project can now be met in full by Braveheart without the requirement to raise any funding from other sources. The cash now allocated to this project is expected to be sufficient to take the project through to a point where the product is ready for commercial launch.